Stay updated on Efficacy of Pexidartinib in TGCT Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Pexidartinib in TGCT Clinical Trial page.

Latest updates to the Efficacy of Pexidartinib in TGCT Clinical Trial page
- Check5 days agoChange DetectedA new revision tag v3.5.4 was added, replacing the previous v3.5.3. This reflects a minor update in the page's revision history.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now shows a new revision tag of v3.5.3, replacing the previous v3.5.2. This indicates a subsequent internal update to the page’s documentation or metadata rather than any modification to the study information.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded Tenosynovial giant cell tumor, diffuse type as a terminology item and a Genetic and Rare Diseases Information Center resource to the study page.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Efficacy of Pexidartinib in TGCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Pexidartinib in TGCT Clinical Trial page.